Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Amur Minerals ( (GB:CRTX) ) just unveiled an announcement.
CRISM Therapeutics Corporation, a company involved in the healthcare and pharmaceuticals industry, has announced a retail offer to raise up to £100,000 through the issuance of new ordinary shares at 9 pence per share. This initiative is part of a broader strategy to fund its Phase 2 clinical trial of irinotecan-ChemoSeed for glioblastoma patients. The retail offer is available to UK investors and is coordinated by SP Angel Corporate Finance LLP. The completion of this offer is contingent upon the admission of the new shares to the AIM market of the London Stock Exchange.
More about Amur Minerals
Average Trading Volume: 74,298
Technical Sentiment Signal: Sell
Current Market Cap: £4.4M
For a thorough assessment of CRTX stock, go to TipRanks’ Stock Analysis page.